Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fulvia Ceccarelli

Showing results (51-60 of 198) with videos related to

Pageof 20
Sort By:
Clinical Rheumatology|October 24, 2007
Etanercept in the treatment of rheumatoid arthritis: clinical follow-up over one year by ultrasonographyAnnamaria Iagnocco, Chiara Perella, Esperanza Naredo, et al.
Immunologic Research|November 28, 2014
Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported casesCarlo Perricone, Fulvia Ceccarelli, Gideon Nesher, et al.
Reumatismo|July 24, 2025
The role of anifrolumab in reshaping the treatment landscape of extra-renal systemic lupus erythematosusFulvia Ceccarelli, Matteo Piga, Alessandra Bortoluzzi, et al.
Clinical and Experimental Rheumatology|October 27, 2016
Assessment of semaphorin 3A and its role in bone remodelling in a group of ankylosing spondylitis patientsFabio Massimo Perrotta, Fulvia Ceccarelli, Cristiana Barbati, et al.
Immunologic Research|October 1, 2024
Belimumab 10 years later: how drug positioning has changedFulvia Ceccarelli, Francesco Natalucci, Claudia Ciancarella, et al.
Autoimmunity Reviews|March 7, 2015
Assessment of disease activity in Systemic Lupus Erythematosus: Lights and shadowsFulvia Ceccarelli, Carlo Perricone, Laura Massaro, et al.
Annals of the Rheumatic Diseases|July 7, 2007
Switching tumour necrosis factor alpha antagonists in patients with ankylosing spondylitis and psoriatic arthritis: an observational study over a 5-year periodFabrizio Conti, Fulvia Ceccarelli, Elisa Marocchi, et al.
Lupus|October 20, 2021
Erosive arthritis in systemic lupus erythematosus: not only RhupusFulvia Ceccarelli, Francesco Natalucci, Giulio Olivieri, et al.
Journal of Immunology Research|June 2, 2018
Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control StudyFabio Massimo Perrotta, Fulvia Ceccarelli, Cristiana Barbati, et al.
Autoimmunity Reviews|June 10, 2023
Organ damage in Systemic Lupus Erythematosus patients: A multifactorial phenomenonFulvia Ceccarelli, Carlo Perricone, Francesco Natalucci, et al.
Pageof 20

Showing results (51-60 of 198) with videos related to

Sort By:
Pageof 20
Clinical Rheumatology|October 24, 2007
Etanercept in the treatment of rheumatoid arthritis: clinical follow-up over one year by ultrasonographyAnnamaria Iagnocco, Chiara Perella, Esperanza Naredo, et al.
Immunologic Research|November 28, 2014
Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported casesCarlo Perricone, Fulvia Ceccarelli, Gideon Nesher, et al.
Reumatismo|July 24, 2025
The role of anifrolumab in reshaping the treatment landscape of extra-renal systemic lupus erythematosusFulvia Ceccarelli, Matteo Piga, Alessandra Bortoluzzi, et al.
Clinical and Experimental Rheumatology|October 27, 2016
Assessment of semaphorin 3A and its role in bone remodelling in a group of ankylosing spondylitis patientsFabio Massimo Perrotta, Fulvia Ceccarelli, Cristiana Barbati, et al.
Immunologic Research|October 1, 2024
Belimumab 10 years later: how drug positioning has changedFulvia Ceccarelli, Francesco Natalucci, Claudia Ciancarella, et al.
Autoimmunity Reviews|March 7, 2015
Assessment of disease activity in Systemic Lupus Erythematosus: Lights and shadowsFulvia Ceccarelli, Carlo Perricone, Laura Massaro, et al.
Annals of the Rheumatic Diseases|July 7, 2007
Switching tumour necrosis factor alpha antagonists in patients with ankylosing spondylitis and psoriatic arthritis: an observational study over a 5-year periodFabrizio Conti, Fulvia Ceccarelli, Elisa Marocchi, et al.
Lupus|October 20, 2021
Erosive arthritis in systemic lupus erythematosus: not only RhupusFulvia Ceccarelli, Francesco Natalucci, Giulio Olivieri, et al.
Journal of Immunology Research|June 2, 2018
Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control StudyFabio Massimo Perrotta, Fulvia Ceccarelli, Cristiana Barbati, et al.
Autoimmunity Reviews|June 10, 2023
Organ damage in Systemic Lupus Erythematosus patients: A multifactorial phenomenonFulvia Ceccarelli, Carlo Perricone, Francesco Natalucci, et al.
Pageof 20